D-Index & Metrics Best Publications
Olivier Delattre

Olivier Delattre

Genetics
France
2023
Medicine
France
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 112 Citations 49,444 585 World Ranking 2954 National Ranking 73
Genetics D-index 113 Citations 48,866 505 World Ranking 284 National Ranking 6

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in France Leader Award

2023 - Research.com Genetics in France Leader Award

2012 - Member of Academia Europaea

Member of the European Molecular Biology Organization (EMBO)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

His main research concerns Cancer research, Genetics, Pathology, Gene and Molecular biology. His Cancer research study integrates concerns from other disciplines, such as Mutation, Germline mutation, Germline, Sarcoma and Neuroblastoma. His study in Neuroblastoma is interdisciplinary in nature, drawing from both Gene duplication, Regulation of gene expression and Immunology.

His Pathology research includes elements of Cancer, Internal medicine, Proportional hazards model, Oncology and Comparative genomic hybridization. His research integrates issues of Immunohistochemistry and Medulloblastoma in his study of Cancer. The Molecular biology study combines topics in areas such as Cellular differentiation, Gene expression profiling, Chromosomal translocation, Chromosome and Transcription.

His most cited work include:

  • Systematic identification of genomic markers of drug sensitivity in cancer cells (1650 citations)
  • Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours (1406 citations)
  • Truncating Mutations of hSNF5/INI1 in Aggressive Paediatric Cancer (1170 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cancer research, Genetics, Pathology, Molecular biology and Neuroblastoma. Olivier Delattre interconnects Carcinogenesis, Cancer, Transcription factor and Sarcoma in the investigation of issues within Cancer research. All of his Genetics and Gene, Chromosome 22, Chromosome, Gene mapping and Locus investigations are sub-components of the entire Genetics study.

The concepts of his Pathology study are interwoven with issues in Internal medicine, Comparative genomic hybridization, Oncology and Gene expression profiling. His Molecular biology study combines topics from a wide range of disciplines, such as Fluorescence in situ hybridization and Chromosomal translocation. His Neuroblastoma study frequently involves adjacent topics like Stage.

He most often published in these fields:

  • Cancer research (38.63%)
  • Genetics (27.17%)
  • Pathology (20.13%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (38.63%)
  • Sarcoma (14.89%)
  • Carcinogenesis (11.13%)

In recent papers he was focusing on the following fields of study:

Olivier Delattre mainly investigates Cancer research, Sarcoma, Carcinogenesis, Neuroblastoma and Cancer. His work deals with themes such as Transcription factor, Immune system, Immunotherapy, SMARCB1 and Pediatric cancer, which intersect with Cancer research. His Pediatric cancer research is within the category of Genetics.

His Sarcoma research incorporates elements of Fusion gene, Transcriptome, Metastasis and Chromosomal translocation. In his research on the topic of Neuroblastoma, Reprogramming and DNA methylation is strongly related with Epigenetics. The Cancer study combines topics in areas such as Disease and Oncology.

Between 2015 and 2021, his most popular works were:

  • Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study (209 citations)
  • Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries (138 citations)
  • Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries (138 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

Olivier Delattre spends much of his time researching Cancer research, Sarcoma, Carcinogenesis, Transcription factor and Cancer. His Cancer research study combines topics in areas such as SMARCB1, Receptor, Neuroblastoma, Rhabdomyosarcoma and Pediatric cancer. His Sarcoma study combines topics from a wide range of disciplines, such as Gerontology, Chromosomal translocation, Transcriptome, Proto-Oncogene Protein c-fli-1 and Promoter.

His study in Transcription factor is interdisciplinary in nature, drawing from both Phenotype, Regulation of gene expression, Neuroscience and Cell biology. He has researched Cancer in several fields, including Disease, Cell growth and Oncology. His Somatic cell study contributes to a more complete understanding of Genetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett;Elena J. Edelman;Sonja J. Heidorn;Christopher Greenman;Christopher Greenman.
Nature (2012)

2279 Citations

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Olivier Delattre;Jessica Zucman;Béatrice Plougastel;Chantal Desmaze.
Nature (1992)

1940 Citations

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

Guy A. Rouleau;Philippe Merel;Mohini Lutchman;Marc Sanson;Marc Sanson.
Nature (1993)

1602 Citations

Truncating Mutations of hSNF5/INI1 in Aggressive Paediatric Cancer

Isabella Versteege;Nicolas Sévenet;Julian Lange;Marie-Françoise Rousseau-Merck.
Nature (1998)

1572 Citations

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

O Delattre;J Zucman;T Melot;X S Garau.
The New England Journal of Medicine (1994)

1209 Citations

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones.
Acta Neuropathologica (2012)

964 Citations

Control-FREEC

Valentina Boeva;Tatiana Popova;Kevin Bleakley;Pierre Chiche.
Bioinformatics (2012)

948 Citations

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Isabelle Janoueix-Lerosey;Delphine Lequin;Delphine Lequin;Laurence Brugières;Agnès Ribeiro.
Nature (2008)

931 Citations

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia.
Nature (2012)

810 Citations

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

Yoon Jae Cho;Aviad Tsherniak;Pablo Tamayo;Sandro Santagata.
Journal of Clinical Oncology (2011)

725 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Olivier Delattre

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 284

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 200

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 141

John M. Maris

John M. Maris

Children's Hospital of Philadelphia

Publications: 132

Paul A. Northcott

Paul A. Northcott

St. Jude Children's Research Hospital

Publications: 108

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 98

Jaclyn A. Biegel

Jaclyn A. Biegel

University of Southern California

Publications: 90

Rogier Versteeg

Rogier Versteeg

University of Amsterdam

Publications: 84

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 82

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 80

Cristina R. Antonescu

Cristina R. Antonescu

Memorial Sloan Kettering Cancer Center

Publications: 75

Poul H. Sorensen

Poul H. Sorensen

University of British Columbia

Publications: 75

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 70

Jo Vandesompele

Jo Vandesompele

Ghent University

Publications: 67

Matthias Fischer

Matthias Fischer

University of Cologne

Publications: 66

Johannes H. Schulte

Johannes H. Schulte

Charité - University Medicine Berlin

Publications: 64

Trending Scientists

Carl Vondrick

Carl Vondrick

Columbia University

Zhinong Ying

Zhinong Ying

Aalborg University

Hidehiko Takara

Hidehiko Takara

NTT (Japan)

Boris F. Minaev

Boris F. Minaev

Royal Institute of Technology

David R. Yarkony

David R. Yarkony

Johns Hopkins University

Madhur Anand

Madhur Anand

University of Guelph

Timo Muotka

Timo Muotka

University of Oulu

Robert K. Booth

Robert K. Booth

Lehigh University

Franco Zunino

Franco Zunino

University of Milan

Torrence V. Johnson

Torrence V. Johnson

Jet Propulsion Lab

Peggy H. Ostrom

Peggy H. Ostrom

Michigan State University

Joseph A. Hill

Joseph A. Hill

The University of Texas Southwestern Medical Center

John W. Finney

John W. Finney

VA Palo Alto Health Care System

John P. Merrill

John P. Merrill

Harvard University

Michael Esterman

Michael Esterman

Boston University

Kazuhiro Nakazawa

Kazuhiro Nakazawa

Nagoya University

Something went wrong. Please try again later.